Literature DB >> 20368741

Ischemic stroke in the elderly: an overview of evidence.

Ruo-Li Chen1, Joyce S Balami, Margaret M Esiri, Liang-Kung Chen, Alastair M Buchan.   

Abstract

Stroke mostly occurs in elderly people and patient outcomes after stroke are highly influenced by age. A better understanding of the causes of stroke in the elderly might have important practical implications not only for clinical management, but also for preventive strategies and future health-care policies. In this Review, we explore the evidence from both human and animal studies relating to the effect of old age-in terms of susceptibility, patient outcomes and response to treatment-on ischemic stroke. Several aging-related changes in the brain have been identified that are associated with an increase in vulnerability to ischemic stroke in the elderly. Furthermore, risk factor profiles for stroke and mechanisms of ischemic injury differ between young and elderly patients. Elderly patients with ischemic stroke often receive less-effective treatment and have poorer outcomes than younger individuals who develop this condition. Neuroprotective agents for ischemic stroke have been sought for decades but none has proved effective in humans. One contributing factor for this translational failure is that most preclinical studies have used young animals. Future research on ischemic stroke should consider age as a factor that influences stroke prevention and treatment, and should focus on the management of acute stroke in the elderly to reduce the incidence and improve outcomes in this vulnerable group.

Entities:  

Mesh:

Year:  2010        PMID: 20368741     DOI: 10.1038/nrneurol.2010.36

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  166 in total

1.  Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain.

Authors:  Susan M Resnick; Dzung L Pham; Michael A Kraut; Alan B Zonderman; Christos Davatzikos
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

2.  White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury.

Authors:  Malee S Fernando; Julie E Simpson; Fiona Matthews; Carol Brayne; Claire E Lewis; Robert Barber; Raj N Kalaria; Gill Forster; Filomena Esteves; Stephen B Wharton; Pamela J Shaw; John T O'Brien; Paul G Ince
Journal:  Stroke       Date:  2006-04-20       Impact factor: 7.914

Review 3.  Neuron numbers and dendritic extent in normal aging and Alzheimer's disease.

Authors:  P D Coleman; D G Flood
Journal:  Neurobiol Aging       Date:  1987 Nov-Dec       Impact factor: 4.673

4.  Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline.

Authors:  Larry B Goldstein; Robert Adams; Mark J Alberts; Lawrence J Appel; Lawrence M Brass; Cheryl D Bushnell; Antonio Culebras; Thomas J Degraba; Philip B Gorelick; John R Guyton; Robert G Hart; George Howard; Margaret Kelly-Hayes; J V Ian Nixon; Ralph L Sacco
Journal:  Stroke       Date:  2006-05-04       Impact factor: 7.914

5.  Acute cerebrovascular disease in women.

Authors:  A Arboix; M Oliveres; L García-Eroles; C Maragall; J Massons; C Targa
Journal:  Eur Neurol       Date:  2001       Impact factor: 1.710

6.  Enhancing the development and approval of acute stroke therapies: Stroke Therapy Academic Industry roundtable.

Authors:  Marc Fisher; Gregory W Albers; Geoffrey A Donnan; Anthony J Furlan; James C Grotta; Chelsea S Kidwell; Ralph L Sacco; Lawrence R Wechsler
Journal:  Stroke       Date:  2005-07-14       Impact factor: 7.914

7.  High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age.

Authors:  Annelies W E Weverling-Rijnsburger; Iris J A M Jonkers; Eric van Exel; Jacobijn Gussekloo; Rudi G J Westendorp
Journal:  Arch Intern Med       Date:  2003-07-14

8.  Cerebral leukoaraiosis in patients with stroke or TIA: clinical correlates and 1-year outcome.

Authors:  S Koton; Y Schwammenthal; O Merzeliak; T Philips; R Tsabari; D Orion; R Dichtiar; D Tanne
Journal:  Eur J Neurol       Date:  2008-12-09       Impact factor: 6.089

9.  Short- and long-term prognosis for very old stroke patients. The Copenhagen Stroke Study.

Authors:  Lars Peter Kammersgaard; H S Jørgensen; J Reith; H Nakayama; P M Pedersen; T S Olsen
Journal:  Age Ageing       Date:  2004-03       Impact factor: 10.668

10.  A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging.

Authors:  Rachael I Scahill; Chris Frost; Rhian Jenkins; Jennifer L Whitwell; Martin N Rossor; Nick C Fox
Journal:  Arch Neurol       Date:  2003-07
View more
  69 in total

1.  Effects of global ischemia and estradiol pretreatment on phosphorylation of Akt, CREB and STAT3 in hippocampal CA1 of young and middle-aged female rats.

Authors:  M De Butte-Smith; R S Zukin; A M Etgen
Journal:  Brain Res       Date:  2012-07-04       Impact factor: 3.252

2.  Increases in cerebrovascular impedance in older adults.

Authors:  Yong-Sheng Zhu; Benjamin Y Tseng; Shigeki Shibata; Benjamin D Levine; Rong Zhang
Journal:  J Appl Physiol (1985)       Date:  2011-05-26

3.  Synergistic effects of age and stress in a rodent model of stroke.

Authors:  Dawn L Merrett; Scott W Kirkland; Gerlinde A Metz
Journal:  Behav Brain Res       Date:  2010-04-29       Impact factor: 3.332

Review 4.  Neural effects of inflammation, cardiovascular disease, and HIV: Parallel, perpendicular, or progressive?

Authors:  C L Nemeth; M Bekhbat; G N Neigh
Journal:  Neuroscience       Date:  2014-09-17       Impact factor: 3.590

5.  Isolated, subtle, neurological abnormalities in neurologically and cognitively healthy aging subjects.

Authors:  Cecilia Camarda; Paola Torelli; Rosolino Camarda; Iacopo Battaglini; Cesare Gagliardo; Roberto Monastero
Journal:  J Neurol       Date:  2015-04-01       Impact factor: 4.849

Review 6.  Targeting the Nrf2-Keap1 antioxidant defence pathway for neurovascular protection in stroke.

Authors:  Alessio Alfieri; Salil Srivastava; Richard C M Siow; Michel Modo; Paul A Fraser; Giovanni E Mann
Journal:  J Physiol       Date:  2011-06-06       Impact factor: 5.182

7.  CDK5 knockdown prevents hippocampal degeneration and cognitive dysfunction produced by cerebral ischemia.

Authors:  Johana A Gutiérrez-Vargas; Alejandro Múnera; Gloria P Cardona-Gómez
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-24       Impact factor: 6.200

8.  Modeling early-onset post-ischemic seizures in aging mice.

Authors:  Chiping Wu; Justin Wang; Jessie Peng; Nisarg Patel; Yayi Huang; Xiaoxing Gao; Salman Aljarallah; James H Eubanks; Robert McDonald; Liang Zhang
Journal:  Exp Neurol       Date:  2015-05-02       Impact factor: 5.330

Review 9.  Neuroprotective action of acute estrogens: animal models of brain ischemia and clinical implications.

Authors:  Tomoko Inagaki; Anne M Etgen
Journal:  Steroids       Date:  2013-02-04       Impact factor: 2.668

10.  Advancing age and ischemia elevate the electric threshold to elicit spreading depolarization in the cerebral cortex of young adult rats.

Authors:  Péter Hertelendy; Ákos Menyhárt; Péter Makra; Zoltán Süle; Tamás Kiss; Gergely Tóth; Orsolya Ivánkovits-Kiss; Ferenc Bari; Eszter Farkas
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.